Protein biomarkers in cancer include overexpressed proteins (e.g., HER2), mutated proteins (including neoantigens and products of gene fusions), or proteins with tumor-specific post-translational modifications (e.g., glycoproteins), all of which can be detected in tumor tissue. The gene discussed is ERBB2; the disease is cancer.